Variant report
Variant | nsv613377 |
---|---|
Chromosome Location | chr9:10342841-10371281 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs553185926 | chr9:10349236-10349237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs573171056 | chr9:10349262-10349263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs555955064 | chr9:10349267-10349268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs139796607 | chr9:10349312-10349313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs558767313 | chr9:10349336-10349337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs372187419 | chr9:10349337-10349338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs575536642 | chr9:10349351-10349352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544662554 | chr9:10349415-10349416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561238947 | chr9:10349425-10349426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs574731065 | chr9:10349431-10349432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs540267595 | chr9:10349442-10349443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs560156659 | chr9:10349448-10349449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs143548615 | chr9:10349449-10349450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs546117096 | chr9:10349495-10349496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562715413 | chr9:10349498-10349499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs531803724 | chr9:10349514-10349515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs386732537 | chr9:10349534-10349535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs12342062 | chr9:10349536-10349537 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs146312006 | chr9:10349564-10349565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182116563 | chr9:10349581-10349582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566508102 | chr9:10349592-10349593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571829129 | chr9:10351810-10351811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs1924083 | chr9:10351875-10351876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs1323492 | chr9:10351898-10351899 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs186584764 | chr9:10351929-10351930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541593633 | chr9:10351947-10351948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs1323491 | chr9:10351990-10351991 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs148320162 | chr9:10351994-10351995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570786536 | chr9:10351997-10351998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs540891665 | chr9:10352006-10352007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs564047195 | chr9:10352037-10352038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs142066739 | chr9:10352089-10352090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192513355 | chr9:10352091-10352092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs563373482 | chr9:10352115-10352116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs529368583 | chr9:10352131-10352132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs549234949 | chr9:10352159-10352160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs1323490 | chr9:10352183-10352184 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs183234593 | chr9:10352188-10352189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs373399087 | chr9:10352226-10352227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs34748049 | chr9:10352232-10352233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs571967597 | chr9:10352242-10352243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542510459 | chr9:10352257-10352258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs557513777 | chr9:10352273-10352274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs187815981 | chr9:10352275-10352276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs35569974 | chr9:10352277-10352278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs553360326 | chr9:10352327-10352328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs535504978 | chr9:10352329-10352330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs192918996 | chr9:10352437-10352438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs571663522 | chr9:10352440-10352441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs74756894 | chr9:10352460-10352461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Attention deficit hyperactivity disorder | 19546859 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:10349200-10349600 | Enhancers | Fetal Brain Male | brain |
2 | chr9:10351800-10352600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr9:10356600-10357800 | Enhancers | Brain Germinal Matrix | brain |
4 | chr9:10357200-10357600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr9:10357200-10358000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
6 | chr9:10357400-10357800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr9:10357400-10358200 | Enhancers | Fetal Brain Female | brain |
8 | chr9:10357600-10358000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr9:10357800-10360200 | Weak transcription | Brain Germinal Matrix | brain |
10 | chr9:10360200-10360600 | Enhancers | Brain Germinal Matrix | brain |
11 | chr9:10360600-10364800 | Weak transcription | Brain Germinal Matrix | brain |
12 | chr9:10364800-10365200 | Enhancers | Brain Germinal Matrix | brain |
13 | chr9:10365200-10369600 | Weak transcription | Brain Germinal Matrix | brain |
14 | chr9:10366000-10366400 | Enhancers | Fetal Brain Male | brain |
15 | chr9:10369600-10370200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr9:10369600-10370200 | Enhancers | Brain Germinal Matrix | brain |
17 | chr9:10370200-10371800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr9:10371200-10371400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |